Table 7.
Concomitant medications and their indications.
| Indication | Generic | N | % |
|---|---|---|---|
| None | None | 52 | 22.9 |
|
| |||
| Thyroid dysfunction | L-Thyroxin | 35 | 14.9 |
| Iodine | 3 | 1.4 | |
|
| |||
| Hypertension | Beta-blocker | 12 | 5.3 |
| Angiotensin-converting enzyme (ACE) inhibitor | 6 | 2.6 | |
| Angiotensin II blocker | 4 | 1.8 | |
| Calcium channel blocker | 5 | 2.2 | |
|
| |||
| Depressive symptoms | SSRI | 11 | 4.8 |
| SNRI | 3 | 1.4 | |
| Herbal agent | 2 | 0.8 | |
|
| |||
| Sleep disturbances | Tricyclic antidepressant | 7 | 3.0 |
| Zopiclone | 1 | 0.5 | |
| SSRI | 1 | 0.5 | |
| Pregabalin | 1 | 0.5 | |
|
| |||
| Stomach pain | Proton pump inhibitor | 16 | 7.0 |
|
| |||
| Vitamin substitution | Vitamin D | 13 | 5.7 |
| Estrogen | 3 | 1.4 | |
|
| |||
| Asthma | Beta II agonist | 11 | 4.6 |
| Corticosteroid | 7 | 3.1 | |
|
| |||
| Other pain disorder | NSAID | 2 | 0.9 |
| Anxiety symptoms | SSRI | 1 | 0.5 |
| Osteoporosis | Vitamin D | 1 | 0.5 |
|
| |||
| Others | 32 | 14.1 | |
N, the number of treatment regimens; %, percentage of the whole cohort.